LAMA2 and facioscapulohumeral muscular dystrophy: In particular, we examine myogenic cells obtained from donors with (i) congenital muscular dystrophy type 1A (MDC1A) due to laminin-alpha-2-deficiency, (ii) limb-girdle muscular dystrophy type 2D (LGMD2D) due to alpha-sarcoglycan-deficiency, and (iii) facioscapulohumeral muscular dystrophy (FSHD) type 1.